Table 3.
The pharmacokinetic parameters of 13–197 in mice and in rats after 5 mg/kg intravenous and 50 mg/kg oral doses (N=5).
PK Parameters | Mice |
Rat |
||
---|---|---|---|---|
IV dose- 5mg/kg |
Oral Dose- 50mg/kg |
IV dose- 5mg/kg (Mean ± SEM |
Oral dose- 50mg/kg (Mean ± SEM) |
|
Tmax (h) | * a) | 1.0 | * | 12.0 ± 4.0 |
Cmax(ng/ml) | * | 340.2 | * | 1049.5 ± 195.1 |
AUClast (ng.h/ml) | 3848 | 1184 | 13819 ± 5693 | 22168 ± 5455 |
AUC0-∞ (ng.h/ml) | 3879 | 1219 | 13848 ± 5683 | 22170 ± 5454 |
λz (1/h) | 0.044 | 0.1623 | 0.087 ± 0.020 | 0.138 ± 0.005 |
t0.5(h) | 15.7 | 4.3 | 9.4 ± 2.1 | 5.0 ± 0.18 |
Vβ (l/kg) | 29.26 | 252.5 | 7.5 ± 2.5 | 21.2 ± 3.4 |
CL (l/hr/kg) | 1.28 | 40.99 | 0.50 ± 0.11 | 2.96 ± 0.53 |
MRT0-∞ (h) | 5.14 | 4.4 | 5.7 ± 1.0 | 14.1 ± 1.7 |
Vss (l/kg) | 6.6 | * | 2.99 ± 1.06 | * |
% bioavailability | * | 3.14 | * | 16.03 |
not applicable